scholarly article | Q13442814 |
P356 | DOI | 10.1111/JGH.12319 |
P8608 | Fatcat ID | release_aeilnaysrjfilmmks4km644pyy |
P698 | PubMed publication ID | 23808938 |
P50 | author | Yasuo Imai | Q79182549 |
P2093 | author name string | Yoshihiko Ueda | |
Tohru Inoue | |||
Hidetsugu Yamagishi | |||
Yuko Ono | |||
Takuya Okamura | |||
Shinichi Ban | |||
Kazunori Fukuda | |||
P2860 | cites work | The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas | Q24312239 |
Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines | Q24597859 | ||
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1 | Q24651576 | ||
CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells | Q28262541 | ||
Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis | Q28303785 | ||
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer | Q29614277 | ||
Cdx1 promotes differentiation in a rat intestinal epithelial cell line. | Q33882050 | ||
DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines | Q34139601 | ||
Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. | Q34790095 | ||
Diagnostic strategies for unknown primary cancer | Q35757876 | ||
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer | Q36054860 | ||
Differential mucin phenotypes and their significance in a variation of colorectal carcinoma | Q36987832 | ||
Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary | Q44231588 | ||
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases | Q46145645 | ||
Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability | Q47420591 | ||
CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation. | Q54700906 | ||
P433 | issue | 12 | |
P304 | page(s) | 1815-1822 | |
P577 | publication date | 2013-12-01 | |
P1433 | published in | Journal of Gastroenterology and Hepatology | Q15764401 |
P1476 | title | Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma | |
P478 | volume | 28 |
Q51648276 | A Critical Evaluation of the PAXgene Tissue Fixation System:  Morphology, Immunohistochemistry, Molecular Biology, and Proteomics. |
Q40978030 | Altered expression of cytokeratin 7 and CD117 in transitional mucosa adjacent to human colorectal cancer |
Q48257136 | Collision tumor consisting of a colorectal adenocarcinoma and dissemination of a gastric adenocarcinoma |
Q51075590 | Poorly differentiated adenocarcinoma of the colon: subsite location and clinicopathologic features. |
Q55223758 | SATB2 Shows Different Profiles Between Appendiceal Adenocarcinomas Ex Goblet Cell Carcinoids and Appendiceal/Colorectal Conventional Adenocarcinomas: An Immunohistochemical Study With Comparison to CDX2. |